首页 | 本学科首页   官方微博 | 高级检索  
检索        

川芎嗪对冠心病患者血脂质过氧化物等含量的影响
引用本文:樊光辉,肖创青,陈菊梅,彭方,叶金玉.川芎嗪对冠心病患者血脂质过氧化物等含量的影响[J].中国中西医结合杂志,1994,14(1):26-27,4,5.
作者姓名:樊光辉  肖创青  陈菊梅  彭方  叶金玉
作者单位:解放军第163医院
基金项目:广州军区科研经费重点资助
摘    要:本研究将59例陈旧性心肌梗塞患者随机分为治疗组31例,组28例。治疗组每天静脉滴注川芎160mg,疗程10天,测定治疗组川芎嗪静脉滴注前后血脂质过氧化物(LPO),超氧化歧基总量,与对照组比较。结果表明:川芎嗪有降低血LPO(P<0.01),提高血SOD活性(P<0.05),增加血巯基总量(P<0.01)的作用;心绞痛症状和发作明显改善,与对照组比较,差异有显著性意义(P<0.05)。川芎嗪降低血

关 键 词:川芎嗪  冠心病  过氧化脂质

Effect of Ligustrazine on Plasma Lipid Peroxidation,Superoxide Dismutase of the Coronary Heart Disease
Authors:Fan Guang-hui  Xiao Chuang-qing  Chen Ju-mei
Abstract:A clinical study on 59 remote myocardial infarction cases were divided randomly into treated group(31 cases) and normal control group (28 cases).Treated group used intravenously injected Ligustrazine 160 mg a day for 10 days.The plasma lipid peroxidation(LPO),superoxide dismutase(SOD)and sulfhydryl group were measured before and after treatment in the treated group,in comparing with normal control group.The results showed the levels of LPO significantly reduced(p<0.01),and SOD,sulfhydryl group was obviously increased after Ligustrazine administration(p<0.05).Attack of angina pectoris was reduced.Between these two group,the difference was significant(P<0.05).Mechanism of Ligustrazine in reducing LPO and increasing SOD could be the inhibiting of platelet aggregation,regulating the TXA2/PGI2 ratio in plasma,protecting mycardial cell membrane and improving the mycardial ischemia.Ligustrazine could reduce the production of LPO due to the accelerating clearance of oxygen free radical.
Keywords:Ligustrazine  coronary heart disease  lipid peroxidation  superoxide dismutase  
本文献已被 CNKI 维普 等数据库收录!
点击此处可从《中国中西医结合杂志》浏览原始摘要信息
点击此处可从《中国中西医结合杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号